Annual CFI
$5.11 M
+$40.18 M+114.56%
December 31, 2023
Summary
- As of February 7, 2025, CAPR annual cash flow from investing activities is $5.11 million, with the most recent change of +$40.18 million (+114.56%) on December 31, 2023.
- During the last 3 years, CAPR annual CFI has fallen by -$331.00 thousand (-6.09%).
- CAPR annual CFI is now -6.09% below its all-time high of $5.44 million, reached on December 31, 2020.
Performance
CAPR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$2.00 M
-$12.69 M-86.36%
September 30, 2024
Summary
- As of February 7, 2025, CAPR quarterly cash flow from investing activities is $2.00 million, with the most recent change of -$12.69 million (-86.36%) on September 30, 2024.
- Over the past year, CAPR quarterly CFI has dropped by -$12.69 million (-86.36%).
- CAPR quarterly CFI is now -86.36% below its all-time high of $14.70 million, reached on June 30, 2024.
Performance
CAPR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$1.33 M
-$5.72 M-81.07%
September 30, 2024
Summary
- As of February 7, 2025, CAPR TTM cash flow from investing activities is $1.33 million, with the most recent change of -$5.72 million (-81.07%) on September 30, 2024.
- Over the past year, CAPR TTM CFI has dropped by -$5.72 million (-81.07%).
- CAPR TTM CFI is now -91.71% below its all-time high of $16.11 million, reached on September 30, 2023.
Performance
CAPR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CAPR Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +114.6% | -86.4% | -81.1% |
3 y3 years | -6.1% | -61.0% | +103.8% |
5 y5 years | +9.3% | -61.0% | +103.8% |
CAPR Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +114.6% | -86.4% | +105.7% | -91.7% | +103.3% |
5 y | 5-year | -6.1% | +114.6% | -86.4% | +105.7% | -91.7% | +103.3% |
alltime | all time | -6.1% | +114.6% | -86.4% | +105.7% | -91.7% | +103.3% |
Capricor Therapeutics Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $2.00 M(-86.4%) | $1.33 M(-81.1%) |
Jun 2024 | - | $14.70 M(-254.7%) | $7.05 M(-696.5%) |
Mar 2024 | - | -$9.50 M(+62.1%) | -$1.18 M(-123.1%) |
Dec 2023 | $5.11 M(-114.6%) | -$5.86 M(-175.9%) | $5.11 M(-68.3%) |
Sep 2023 | - | $7.72 M(+19.5%) | $16.11 M(+282.3%) |
Jun 2023 | - | $6.46 M(-301.2%) | $4.21 M(-111.2%) |
Mar 2023 | - | -$3.21 M(-162.5%) | -$37.66 M(+7.4%) |
Dec 2022 | -$35.07 M(+2831.7%) | $5.14 M(-223.1%) | -$35.07 M(-13.6%) |
Sep 2022 | - | -$4.18 M(-88.2%) | -$40.58 M(+10.1%) |
Jun 2022 | - | -$35.41 M(+5562.4%) | -$36.87 M(+1966.1%) |
Mar 2022 | - | -$625.40 K(+69.6%) | -$1.78 M(+49.2%) |
Dec 2021 | -$1.20 M(-122.0%) | -$368.70 K(-21.3%) | -$1.20 M(+7.2%) |
Sep 2021 | - | -$468.20 K(+45.2%) | -$1.12 M(+39.5%) |
Jun 2021 | - | -$322.50 K(+774.0%) | -$799.50 K(+36.8%) |
Mar 2021 | - | -$36.90 K(-87.2%) | -$584.50 K(-110.7%) |
Dec 2020 | $5.44 M(-281.2%) | -$288.10 K(+89.5%) | $5.44 M(-2196.0%) |
Sep 2020 | - | -$152.00 K(+41.4%) | -$259.50 K(+141.4%) |
Jun 2020 | - | -$107.50 K(-101.8%) | -$107.50 K(<-9900.0%) |
Mar 2020 | - | $5.99 M(-200.0%) | $0.00(-100.0%) |
Dec 2019 | -$3.00 M(-164.3%) | -$5.99 M(<-9900.0%) | -$3.00 M(-150.1%) |
Sep 2019 | - | $0.00(0.0%) | $5.99 M(+2.4%) |
Jun 2019 | - | $0.00(-100.0%) | $5.85 M(+0.0%) |
Mar 2019 | - | $2.98 M(-0.7%) | $5.84 M(+25.1%) |
Dec 2018 | $4.67 M(-6.2%) | $3.00 M(-2207.2%) | $4.67 M(-454.8%) |
Sep 2018 | - | -$142.60 K(+7030.0%) | -$1.32 M(-39.8%) |
Jun 2018 | - | -$2000.00(-100.1%) | -$2.19 M(-178.4%) |
Mar 2018 | - | $1.81 M(-160.7%) | $2.79 M(-43.9%) |
Dec 2017 | $4.98 M(-196.0%) | -$2.98 M(+194.2%) | $4.98 M(-289.6%) |
Sep 2017 | - | -$1.01 M(-120.4%) | -$2.63 M(+61.4%) |
Jun 2017 | - | $4.98 M(+24.5%) | -$1.63 M(-75.5%) |
Mar 2017 | - | $4.00 M(-137.8%) | -$6.64 M(+27.9%) |
Dec 2016 | -$5.19 M(-36.2%) | -$10.59 M(>+9900.0%) | -$5.19 M(-149.9%) |
Sep 2016 | - | -$14.60 K(-53.8%) | $10.39 M(-18.9%) |
Jun 2016 | - | -$31.60 K(-100.6%) | $12.82 M(-0.1%) |
Mar 2016 | - | $5.45 M(+9.1%) | $12.83 M(-257.6%) |
Dec 2015 | -$8.14 M(-5873.7%) | $4.99 M(+106.8%) | -$8.14 M(-36.2%) |
Sep 2015 | - | $2.41 M(<-9900.0%) | -$12.76 M(-16.3%) |
Jun 2015 | - | -$23.30 K(-99.8%) | -$15.24 M(-0.3%) |
Mar 2015 | - | -$15.52 M(-4235.5%) | -$15.29 M(<-9900.0%) |
Dec 2014 | $141.00 K(-96.3%) | $375.40 K(-628.0%) | $141.00 K(-86.5%) |
Sep 2014 | - | -$71.10 K(+3.0%) | $1.04 M(-53.0%) |
Jun 2014 | - | -$69.00 K(-26.8%) | $2.21 M(-31.9%) |
Mar 2014 | - | -$94.30 K(-107.4%) | $3.25 M(-13.9%) |
Dec 2013 | $3.78 M(-187.5%) | $1.28 M(+15.8%) | $3.78 M(-308.2%) |
Sep 2013 | - | $1.10 M(+13.7%) | -$1.81 M(-37.8%) |
Jun 2013 | - | $969.60 K(+125.0%) | -$2.92 M(-24.9%) |
Mar 2013 | - | $431.00 K(-110.0%) | -$3.89 M(-10.0%) |
Dec 2012 | -$4.32 M | -$4.32 M(<-9900.0%) | -$4.32 M(>+9900.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2012 | - | $0.00(0.0%) | -$2000.00(0.0%) |
Jun 2012 | - | $0.00(0.0%) | -$2000.00(0.0%) |
Mar 2012 | - | $0.00(-100.0%) | -$2000.00(0.0%) |
Dec 2011 | -$2000.00(-9.1%) | -$2000.00(<-9900.0%) | -$2000.00(-9.1%) |
Sep 2011 | - | $0.00(0.0%) | -$2200.00(0.0%) |
Jun 2011 | - | $0.00(0.0%) | -$2200.00(0.0%) |
Mar 2011 | - | $0.00(-100.0%) | -$2200.00(0.0%) |
Dec 2010 | -$2200.00(-93.6%) | -$2200.00(<-9900.0%) | -$2200.00(-833.3%) |
Sep 2010 | - | $0.00(0.0%) | $300.00(-101.3%) |
Jun 2010 | - | $0.00(-100.0%) | -$23.40 K(-31.6%) |
Dec 2009 | -$34.20 K(-63.1%) | $300.00(-101.3%) | -$34.20 K(-30.9%) |
Sep 2009 | - | -$23.70 K(+192.6%) | -$49.50 K(+46.4%) |
Jun 2009 | - | -$8100.00(+200.0%) | -$33.80 K(-46.3%) |
Mar 2009 | - | -$2700.00(-82.0%) | -$62.90 K(-32.1%) |
Dec 2008 | -$92.60 K(-67.9%) | -$15.00 K(+87.5%) | -$92.70 K(-58.7%) |
Sep 2008 | - | -$8000.00(-78.5%) | -$224.30 K(-26.4%) |
Jun 2008 | - | -$37.20 K(+14.5%) | -$304.80 K(+1.9%) |
Mar 2008 | - | -$32.50 K(-77.8%) | -$299.20 K(+3.6%) |
Dec 2007 | -$288.90 K(+435.0%) | -$146.60 K(+65.6%) | -$288.90 K(+47.2%) |
Sep 2007 | - | -$88.50 K(+180.1%) | -$196.30 K(+82.1%) |
Jun 2007 | - | -$31.60 K(+42.3%) | -$107.80 K(+41.5%) |
Mar 2007 | - | -$22.20 K(-58.9%) | -$76.20 K(+41.1%) |
Dec 2006 | -$54.00 K(<-9900.0%) | -$54.00 K(<-9900.0%) | -$54.00 K(<-9900.0%) |
Sep 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2005 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2004 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2003 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2002 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2001 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2001 | - | $0.00 | $0.00 |
Dec 2000 | $0.00(0.0%) | - | - |
Dec 1999 | $0.00 | - | - |
FAQ
- What is Capricor Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Capricor Therapeutics?
- What is Capricor Therapeutics annual CFI year-on-year change?
- What is Capricor Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly CFI year-on-year change?
- What is Capricor Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Capricor Therapeutics?
- What is Capricor Therapeutics TTM CFI year-on-year change?
What is Capricor Therapeutics annual cash flow from investing activities?
The current annual CFI of CAPR is $5.11 M
What is the all time high annual CFI for Capricor Therapeutics?
Capricor Therapeutics all-time high annual cash flow from investing activities is $5.44 M
What is Capricor Therapeutics annual CFI year-on-year change?
Over the past year, CAPR annual cash flow from investing activities has changed by +$40.18 M (+114.56%)
What is Capricor Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of CAPR is $2.00 M
What is the all time high quarterly CFI for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly cash flow from investing activities is $14.70 M
What is Capricor Therapeutics quarterly CFI year-on-year change?
Over the past year, CAPR quarterly cash flow from investing activities has changed by -$12.69 M (-86.36%)
What is Capricor Therapeutics TTM cash flow from investing activities?
The current TTM CFI of CAPR is $1.33 M
What is the all time high TTM CFI for Capricor Therapeutics?
Capricor Therapeutics all-time high TTM cash flow from investing activities is $16.11 M
What is Capricor Therapeutics TTM CFI year-on-year change?
Over the past year, CAPR TTM cash flow from investing activities has changed by -$5.72 M (-81.07%)